News
The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed. Listeria monocytogenes can lead to severe and sometimes fatal infections, ...
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
Class II recalls from the FDA indicate a potential risk to consumer safety where use or exposure to the product may cause ...
The FDA recalled some chocolate products by the Weaver Nut Company chocolate, warning about possible serious to ...
The FDA published more than 200 letters that it sent to companies when it rejected their medicines, but the letters came with ...
The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's experimental gene therapy to treat ...
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...
The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...
The U.S. Food and Drug Administration on Thursday publicly shared over 200 archived so-called complete response letters related to medicines that were later approved, in a bid to improve transparency ...
The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care The Big Story Senate panel clears ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results